Pancreatic Cancer Trial, Recruiting NCT07647250 Sponsor: University of Illinois at Chicago Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT07647250
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with pancreatic cancer that the treating medical team considers potentially removable by surgery
  • People who are planned to receive, or are already receiving, chemotherapy before surgery
  • People who have been assessed as "frail" or "pre-frail" using the specific frailty measurement tool used in this study (confirm with trial site for details on how this is assessed)
  • People who are able to sign a written consent form
  • People whose doctors consider supervised, guided exercise to be medically appropriate for them
  • People who are able to complete study forms and questionnaires in either English or Spanish

Who may not be able to join:

  • People who are not able to give their own consent to participate
  • People with a medical condition that a study doctor considers makes exercise unsafe — for example, unstable chest pain, an uncontrolled irregular heartbeat, severe heart failure, or uncontrolled serious lung disease
  • People with any medical reason that completely rules out exercise participation or testing, according to the standards of the institution running the trial
  • People with severe symptoms or physical limitations that prevent safe participation, even with adjustments to the program
  • People who are unable to follow the trial schedule and procedures, even when the study team makes reasonable efforts to accommodate them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 312 996 6666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
22 June 2026
Est. completion
30 April 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recruitment rate; Retention rate; Adherence rate; Exercise-related adverse events (AEs) and serious adverse events (SAEs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov